MindBio Therapeutics has received ethics approval for a Phase II trial of microdoses of Lysergic Acid Diethylamide (LSD) and Meaning Centred Psychotherapy for the treatment of patients with advanced-stage cancer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,